Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis

THE WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 19 STUDY GROUP

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences